We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
-2.77%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$122M
AUM Growth
+$5.73M
Cap. Flow
+$9.14M
Cap. Flow %
7.49%
Top 10 Hldgs %
19.81%
Holding
203
New
41
Increased
58
Reduced
51
Closed
31

Top Sells

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$1.63M
2
KLAC icon
KLA
KLAC
+$1.36M
3
DD icon
DuPont de Nemours
DD
+$1.29M
4
TSN icon
Tyson Foods
TSN
+$1.09M
5
STLD icon
Steel Dynamics
STLD
+$880K

Sector Composition

Rank Sector Weight
1 Industrials 21.38%
2 Healthcare 19.69%
3 Consumer Staples 12.76%
4 Technology 12.03%
5 Financials 11.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DD
26
DELISTED
Du Pont De Nemours E I
DD
$1.17M 0.96%
+19,270
New +$1.3M
MSFT icon
27
Microsoft
MSFT
$3.71T
$1.13M 0.93%
25,648
+1,900
+8% +$86.7K
EAT icon
28
Brinker International
EAT
$9.75B
$1.12M 0.92%
19,491
+5,725
+42% +$328K
EMC
29
DELISTED
EMC CORPORATION
EMC
$1.12M 0.92%
42,525
+3,650
+9% +$97.3K
BNY
30
Bank of New York Mellon
BNY
$108B
$1.12M 0.91%
26,600
-1,800
-6% -$76.7K
CP icon
31
Canadian Pacific Kansas City
CP
$79.3B
$1.11M 0.91%
34,515
+6,180
+22% +$221K
KMI icon
32
Kinder Morgan
KMI
$69.7B
$1.09M 0.89%
28,394
+19,000
+202% +$793K
MMM icon
33
3M
MMM
$93.2B
$1.09M 0.89%
8,423
+3,352
+66% +$450K
PLL
34
DELISTED
PALL CORP
PLL
$1.05M 0.86%
8,479
+704
+9% +$79.5K
IHG icon
35
InterContinental Hotels
IHG
$23.5B
$1.05M 0.86%
19,607
-15,153
-44% -$840K
AVT icon
36
Avnet
AVT
$7.94B
$990K 0.81%
24,075
-6,150
-20% -$271K
CNW
37
DELISTED
CON-WAY INC.
CNW
$983K 0.81%
25,625
-550
-2% -$22.8K
GSK icon
38
GSK
GSK
$104B
$982K 0.8%
18,867
+931
+5% +$52.4K
MDT icon
39
Medtronic
MDT
$110B
$975K 0.8%
13,160
+5,025
+62% +$384K
IBM icon
40
IBM
IBM
$220B
$962K 0.79%
6,187
-272
-4% -$43.7K
INDB icon
41
Independent Bank
INDB
$4B
$951K 0.78%
20,278
-250
-1% -$11.1K
BDC icon
42
Belden
BDC
$5.05B
$950K 0.78%
11,700
+4,450
+61% +$390K
VTRS icon
43
Viatris
VTRS
$19B
$931K 0.76%
13,725
+8,550
+165% +$604K
GILD icon
44
Gilead Sciences
GILD
$162B
$919K 0.75%
7,850
-1,900
-19% -$208K
ADI icon
45
Analog Devices
ADI
$184B
$913K 0.75%
14,225
-450
-3% -$29.2K
CSCO icon
46
Cisco
CSCO
$476B
$898K 0.74%
32,696
-2,400
-7% -$68.8K
TRN icon
47
Trinity Industries
TRN
$2.47B
$897K 0.73%
47,157
+22,502
+91% +$504K
NKE icon
48
Nike
NKE
$62.3B
$886K 0.73%
16,402
-798
-5% -$40.9K
SLB icon
49
SLB Ltd
SLB
$76.5B
$871K 0.71%
10,107
+1,500
+17% +$135K
AAL icon
50
American Airlines Group
AAL
$10.6B
$844K 0.69%
+21,125
New +$963K

Similar funds

New England Research & Management's Q2 2015 Portfolio in Review

As of Q2 2015, New England Research & Management held 203 positions worth $122M, up 4.9% from $116M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

New England Research & Management deployed $9.14M of net new capital in Q2 2015, opening 41 new positions and adding to 58 existing holdings. Its largest new stake was Du Pont De Nemours E I: 19,270 shares worth $1.17M.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was Qualcomm, an estimated $1.63M trimmed.

  • New England Research & Management's largest Q2 2015 buy was Du Pont De Nemours E I: 19,270 shares worth $1.17M.
  • New England Research & Management added most to Church & Dwight Co in Q2 2015, an estimated $2.21M increase.
  • New England Research & Management's biggest Q2 2015 reduction was Qualcomm, cutting an estimated $1.63M.
  • New England Research & Management fully exited DuPont de Nemours in Q2 2015, selling an estimated $1.29M.
  • New England Research & Management's ten largest holdings make up 20% of its $122M portfolio in Q2 2015.
  • New England Research & Management opened 41 new positions and closed 31 in Q2 2015.
  • New England Research & Management's portfolio value rose 4.9% quarter-over-quarter to $122M.

Based on New England Research & Management's 13F filing for Q2 2015, filed 7 Jul 2015.